BR0313121A - Immunogenic composition, vaccine, methods of treatment or prevention of neisserial disease, preparation of immunogenic composition, preparation of vaccine, preparation of an immunoglobin for use in the prevention or treatment of neisserial infection, and treatment or prevention of neisserial infection, uses of vaccine and pharmaceutical preparation, genetically engineered neisserial strain, immunoglobin, and pharmaceutical composition - Google Patents

Immunogenic composition, vaccine, methods of treatment or prevention of neisserial disease, preparation of immunogenic composition, preparation of vaccine, preparation of an immunoglobin for use in the prevention or treatment of neisserial infection, and treatment or prevention of neisserial infection, uses of vaccine and pharmaceutical preparation, genetically engineered neisserial strain, immunoglobin, and pharmaceutical composition

Info

Publication number
BR0313121A
BR0313121A BR0313121-1A BR0313121A BR0313121A BR 0313121 A BR0313121 A BR 0313121A BR 0313121 A BR0313121 A BR 0313121A BR 0313121 A BR0313121 A BR 0313121A
Authority
BR
Brazil
Prior art keywords
preparation
prevention
neisserial
treatment
vaccine
Prior art date
Application number
BR0313121-1A
Other languages
Portuguese (pt)
Inventor
Francois-Xavier Jacque Berthet
Ralph Biemans
Philippe Denoel
Christiane Feron
Carine Coraj
Jan Poolman
Vincent Weynants
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0218036A external-priority patent/GB0218036D0/en
Priority claimed from GB0218051A external-priority patent/GB0218051D0/en
Priority claimed from GB0218035A external-priority patent/GB0218035D0/en
Priority claimed from GB0218037A external-priority patent/GB0218037D0/en
Priority claimed from GBGB0220199.4A external-priority patent/GB0220199D0/en
Priority claimed from GBGB0220197.8A external-priority patent/GB0220197D0/en
Priority claimed from GB0225531A external-priority patent/GB0225531D0/en
Priority claimed from GB0225524A external-priority patent/GB0225524D0/en
Priority claimed from GB0230170A external-priority patent/GB0230170D0/en
Priority claimed from GB0230164A external-priority patent/GB0230164D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Priority claimed from PCT/EP2003/008571 external-priority patent/WO2004014418A2/en
Publication of BR0313121A publication Critical patent/BR0313121A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"COMPOSIçãO IMUNOGêNICA, VACINA, MéTODOS DE TRATAMENTO OU PREVENçãO DE DOENçA NEISSERIAL, DE PREPARAçãO DA COMPOSIçãO IMUNOGêNICA, DE PREPARAçãO DA VACINA, DE PREPARAçãO DE UMA IMUNOGLOBULINA PARA USO NA PREVENçãO OU TRATAMENTO DE INFECçãO NEISSERIAL, E DE TRATAMENTO OU PREVENçãO DE INFECçãO NEISSERIAL, USOS DA VACINA E DA PREPARAçãO FARMACêUTICA, CEPA NEISSERIAL GENETICAMENTE ENGENHEIRADA, IMUNOGLOBULINA, E, COMPOSIçãO FARMACêUTICA". A presente invenção refere-se a vacinas e composições imunogênicas para o tratamento e a prevenção de doença neisserial. Composições imunogênicas da invenção contêm combinações de antígenos selecionados de pelo menos duas classes diferentes de antígenos incluindo adesinas, proteínas auto-transportadoras, toxinas, proteínas de aquisição de ferro e proteína(s) associada(s) com membrana (de preferência proteína de membrana exterior integral). Referidas combinações de antígenos são capazes de objetivar a resposta imunológica contra diferentes aspectos do ciclo de vida neisserial, resultando em uma resposta imunológica mais eficaz."IMMUNOGENIC COMPOSITION, VACCIN, METHODS OF TREATMENT OR PREVENTION OF NEISSERIAL DISEASE, PREPARATION OF IMMUNOGENIC COMPOSITION, PREPARATION OF AN IMMUNOGLOBULIN FOR PREVENTION OR PREVENTION OF INFECTION, OR PREVENTION USES OF VACCINE AND PHARMACEUTICAL PREPARATION, GENETICALLY ENGINEED NEISSERIAL CUP, IMMUNOGLOBULIN, AND PHARMACEUTICAL COMPOSITION ". The present invention relates to vaccines and immunogenic compositions for the treatment and prevention of neisserial disease. Immunogenic compositions of the invention contain selected antigen combinations of at least two different antigen classes including adhesins, self-transporting proteins, toxins, iron acquisition proteins and membrane associated protein (s) (preferably outer membrane protein). integral). Such antigen combinations are able to target the immune response against different aspects of the neisserial life cycle, resulting in a more effective immune response.

BR0313121-1A 2002-08-02 2003-07-31 Immunogenic composition, vaccine, methods of treatment or prevention of neisserial disease, preparation of immunogenic composition, preparation of vaccine, preparation of an immunoglobin for use in the prevention or treatment of neisserial infection, and treatment or prevention of neisserial infection, uses of vaccine and pharmaceutical preparation, genetically engineered neisserial strain, immunoglobin, and pharmaceutical composition BR0313121A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
GB0218035A GB0218035D0 (en) 2002-08-02 2002-08-02 Vaccine composition
GB0218037A GB0218037D0 (en) 2002-08-02 2002-08-02 Vaccine composition
GB0218036A GB0218036D0 (en) 2002-08-02 2002-08-02 Vaccine
GB0218051A GB0218051D0 (en) 2002-08-02 2002-08-02 Vaccine composition
GBGB0220199.4A GB0220199D0 (en) 2002-08-30 2002-08-30 Mutant protein and refolding method
GBGB0220197.8A GB0220197D0 (en) 2002-08-30 2002-08-30 Refolding method
GB0225531A GB0225531D0 (en) 2002-11-01 2002-11-01 Vaccine
GB0225524A GB0225524D0 (en) 2002-11-01 2002-11-01 Vaccine composition
GB0230170A GB0230170D0 (en) 2002-12-24 2002-12-24 Vaccine
GB0230164A GB0230164D0 (en) 2002-12-24 2002-12-24 Vaccine composition
PCT/EP2003/008571 WO2004014418A2 (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens

Publications (1)

Publication Number Publication Date
BR0313121A true BR0313121A (en) 2005-10-18

Family

ID=35151537

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313121-1A BR0313121A (en) 2002-08-02 2003-07-31 Immunogenic composition, vaccine, methods of treatment or prevention of neisserial disease, preparation of immunogenic composition, preparation of vaccine, preparation of an immunoglobin for use in the prevention or treatment of neisserial infection, and treatment or prevention of neisserial infection, uses of vaccine and pharmaceutical preparation, genetically engineered neisserial strain, immunoglobin, and pharmaceutical composition

Country Status (1)

Country Link
BR (1) BR0313121A (en)

Similar Documents

Publication Publication Date Title
PL399214A1 (en) Vaccine preparation
AU2005214061B2 (en) Polypeptides for inducing a protective immune response against Staphylococcus aureus
AU2006206577B2 (en) Polypeptides for inducing a protective immune response against Staphylococcus aureus
BRPI0212999B1 (en) new immunogenic compositions for the prevention and treatment of meningococcal disease
BRPI0407877A (en) peptide-protein conjugate, vaccine for the prevention or amelioration of influenza virus infection, and, method for inducing an immune response in a patient
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
US20070243205A1 (en) Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
BR0211296A (en) Immunogenic peptide derived from subgroup a or b vrs protein g, nucleic acid sequence, pharmaceutical composition, polyclonal or monoclonal antibodies, diagnostic kit, use of an immunogenic peptide, and, conjugate
US20070264278A1 (en) Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
US20080095792A1 (en) Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus
EP1556513A4 (en) Compositions and methods for treating human papillomavirus-mediated disease
WO2002092131A3 (en) Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
BR112022020438A2 (en) COMPOSITIONS COMPRISING THREE OSPA FUSION PROTEINS FOR MEDICAL USE
BR0313121A (en) Immunogenic composition, vaccine, methods of treatment or prevention of neisserial disease, preparation of immunogenic composition, preparation of vaccine, preparation of an immunoglobin for use in the prevention or treatment of neisserial infection, and treatment or prevention of neisserial infection, uses of vaccine and pharmaceutical preparation, genetically engineered neisserial strain, immunoglobin, and pharmaceutical composition
JP2010516279A (en) Polypeptide for inducing a protective immune response against Staphylococcus epidermidis
DK1146889T3 (en) Identification of Specific Differentially Expressed Mycobacterial Antigens and Medical Use of Mycobacterium Proteins Rv0068 and Rv3407
US20100104591A1 (en) Polypeptides for inducing a protective immune response against staphylococcus epidermidis
EP1535928A3 (en) Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof
WO2006121664A2 (en) Polypeptides for inducing a protective immune response against staphylococcus aureus
JP2004262847A (en) Vaccine preparation
RU2006123434A (en) PROTEIN NMB1125 AND ITS APPLICATION IN PHARMACEUTICAL COMPOSITIONS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]